BSE filing, NSE: NUVAMA. Summary written from the filing by ALFA Finder's alert engine.
Nuvama Wealth Management Ltd: key numbers
- Share price
- ₹1,744.70
- Market cap
- ₹32,192 Cr
- Revenue (annual)
- ₹4,631 Cr
- Net profit (annual)
- ₹1,041 Cr
- P/E (TTM)
- 29.7×Sector 19.7×
- Promoter holding
- 53.40%-0.58% QoQ
- FII holding
- 19.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nuvama Wealth Management Ltd
All →Nuvama Wealth Management Regulatory Approval
Nuvama Asset Management, a subsidiary of the company, received SEBI approval to establish a Specialized Investment Fund, enabling the launch of its Numa SIF platform.
Nuvama Wealth Management Price Movement Clarification
Nuvama Wealth Management replied to a BSE volume-movement surveillance query. The company confirmed no undisclosed event or UPSI exists requiring Regulation 30 disclosure.
Nuvama Wealth Management Annual General Meeting
Nuvama Wealth Management held its 33rd Annual General Meeting on September 28, 2026. The meeting approved standard business resolutions, including the issuance of Non-convertible Debentures.
Nuvama Wealth Management Share Pledge
PAGAC Ecstasy, a Nuvama promoter, disclosed an increase in underlying loan amounts secured by its existing pledge of 9.69 crore shares (52.57%). No new shares were encumbered.
Nuvama Wealth Management Debt & Borrowing: ₹50 Cr
Nuvama Wealth Management has completed the full redemption of its Commercial Papers valued at ₹50 Crore upon maturity. This repayment clears the outstanding debt.
- Value
- ₹50.00 Cr
Nuvama Wealth Management Share Pledge
Promoter PAGAC Ecstasy Pte. Ltd. created an encumbrance on its shares in Nuvama Wealth Management. This disclosure fulfills regulatory requirements regarding promoter share pledges.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date